Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Gains from Investment Securities (2016 - 2025)

United Therapeutics (UTHR) has disclosed Gains from Investment Securities for 17 consecutive years, with $600000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 100.22% to $600000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.6 million through Dec 2025, up 36.07% year-over-year, with the annual reading at $16.6 million for FY2025, 36.07% up from the prior year.
  • Gains from Investment Securities hit $600000.0 in Q4 2025 for United Therapeutics, up from -$237.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $277.8 million in Q3 2024 to a low of -$277.1 million in Q4 2024.
  • Historically, Gains from Investment Securities has averaged -$1.7 million across 5 years, with a median of $200000.0 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 32050.0% in 2022 and later skyrocketed 263200.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $200000.0 in 2021, then tumbled by 32050.0% to -$63.9 million in 2022, then skyrocketed by 86.23% to -$8.8 million in 2023, then plummeted by 3048.86% to -$277.1 million in 2024, then soared by 100.22% to $600000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for UTHR at $600000.0 in Q4 2025, -$237.9 million in Q3 2025, and $263.3 million in Q2 2025.